2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease

doctor meeting with senior patient using digital tablet
  • VHD prevalence in the United States is 2.5% with no difference between males and females.
  • Valvular heart disease management is rapidly evolving, with advances in diagnostic imaging, and improvements in catheter-based and surgical interventions.
  • This update of the 2014 guidelines on the management of patients with heart valve disease includes changes in indications for:
    • Antibiotic prophylaxis for infective endocarditis (IE)
    • The use of direct oral anticoagulants (DOACs) among patients with atrial fibrillation and heart valve disease
    • Indications for transcatheter aortic valve replacement (TAVR)
    • Surgical management of patients with primary and secondary mitral regurgitation (MR)
    • Management of patients with a heart valve prosthesis